86 related articles for article (PubMed ID: 9071433)
1. Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals.
Balotta C; Bagnarelli P; Riva C; Valenza A; Antinori S; Colombo MC; Sampaolesi R; Violin M; de Pasquale MP; Moroni M; Clementi M; Galli M
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):337-41. PubMed ID: 9071433
[TBL] [Abstract][Full Text] [Related]
2. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course?
Jurriaans S; Van Gemen B; Weverling GJ; Van Strijp D; Nara P; Coutinho R; Koot M; Schuitemaker H; Goudsmit J
Virology; 1994 Oct; 204(1):223-33. PubMed ID: 7916514
[TBL] [Abstract][Full Text] [Related]
3. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.
Lefrère JJ; Morand-Joubert L; Mariotti M; Bludau H; Burghoffer B; Petit JC; Roudot-Thoraval F
Blood; 1997 Aug; 90(3):1133-40. PubMed ID: 9242545
[TBL] [Abstract][Full Text] [Related]
4. Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection.
Pontesilli O; Carotenuto P; Kerkhof-Garde SR; Roos MT; Keet IP; Coutinho RA; Goudsmit J; Miedema F
AIDS Res Hum Retroviruses; 1999 Jul; 15(11):973-81. PubMed ID: 10445809
[TBL] [Abstract][Full Text] [Related]
5. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
[TBL] [Abstract][Full Text] [Related]
6. Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis.
Balotta C; Bagnarelli P; Corvasce S; Mazzucchelli R; Colombo MC; Papagno L; Santambrogio S; Ridolfo AL; Violin M; Berlusconi A; Velleca R; Facchi G; Moroni M; Clementi M; Galli M
J Infect Dis; 1999 Aug; 180(2):285-9. PubMed ID: 10395841
[TBL] [Abstract][Full Text] [Related]
7. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons.
Bruisten SM; Frissen PH; Van Swieten P; Harrigan PR; Kinghorn I; Larder B; Weigel HM; De Vries E; Regez RM; Henrichs JH; Koot M; Huisman JG
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):327-35. PubMed ID: 9071432
[TBL] [Abstract][Full Text] [Related]
8. Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons.
Vesanen M; Stevens CE; Taylor PE; Rubinstein P; Saksela K
J Virol; 1996 Dec; 70(12):9035-40. PubMed ID: 8971039
[TBL] [Abstract][Full Text] [Related]
9. Plasma viremia titration and RNA quantitation in ICD-p24 negative HIV type-1-infected patients.
Ercoli L; Sarmati L; el-Sawaf G; Cochi S; Lanti T; Iudicone P; Guglielmetti M; Giannini G; Galluzzo C; Tomino C
AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1203-7. PubMed ID: 8573376
[TBL] [Abstract][Full Text] [Related]
10. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.
Cao Y; Qin L; Zhang L; Safrit J; Ho DD
N Engl J Med; 1995 Jan; 332(4):201-8. PubMed ID: 7808485
[TBL] [Abstract][Full Text] [Related]
11. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
Cao Y; Ho DD; Todd J; Kokka R; Urdea M; Lifson JD; Piatak M; Chen S; Hahn BH; Saag MS
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):353-61. PubMed ID: 7786581
[TBL] [Abstract][Full Text] [Related]
13. Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors.
Rusconi S; Berlusconi A; Papagno L; Colombo MC; De Maddalena C; Riva A; Bagnarelli P; Balotta C; Galli M
Clin Immunol Immunopathol; 1997 Dec; 85(3):320-3. PubMed ID: 9400632
[TBL] [Abstract][Full Text] [Related]
14. Relationship of virologic, immunologic, and clinical parameters in infants with vertically acquired human immunodeficiency virus type 1 infection.
Muñoz-Fernández MA; Obregón E; Navarro J; Börner C; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
Pediatr Res; 1996 Oct; 40(4):597-602. PubMed ID: 8888289
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors.
Montefiori DC; Pantaleo G; Fink LM; Zhou JT; Zhou JY; Bilska M; Miralles GD; Fauci AS
J Infect Dis; 1996 Jan; 173(1):60-7. PubMed ID: 8537683
[TBL] [Abstract][Full Text] [Related]
16. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection.
Pantaleo G; Menzo S; Vaccarezza M; Graziosi C; Cohen OJ; Demarest JF; Montefiori D; Orenstein JM; Fox C; Schrager LK
N Engl J Med; 1995 Jan; 332(4):209-16. PubMed ID: 7808486
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression.
Poropatich K; Sullivan DJ
J Gen Virol; 2011 Feb; 92(Pt 2):247-68. PubMed ID: 21106806
[TBL] [Abstract][Full Text] [Related]
18. Relationship between human immunodeficiency virus type 1 (HIV-1)-specific memory cytotoxic T lymphocytes and virus load after recent HIV-1 seroconversion.
Connick E; Schlichtemeier RL; Purner MB; Schneider KM; Anderson DM; MaWhinney S; Campbell TB; Kuritzkes DR; Douglas JM; Judson FN; Schooley RT
J Infect Dis; 2001 Dec; 184(11):1465-9. PubMed ID: 11709791
[TBL] [Abstract][Full Text] [Related]
19. Hemophilia and nonprogressing human immunodeficiency virus type 1 infection.
Vicenzi E; Bagnarelli P; Santagostino E; Ghezzi S; Alfano M; Sinnone MS; Fabio G; Turchetto L; Moretti G; Lazzarin A; Mantovani A; Mannucci PM; Clementi M; Gringeri A; Poli G
Blood; 1997 Jan; 89(1):191-200. PubMed ID: 8978292
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors.
Broström C; Visco-Comandini U; Yun Z; Sönnerborg A
J Infect Dis; 1999 Jun; 179(6):1542-8. PubMed ID: 10228079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
